📣 VC round data is live. Check it out!
- Public Comps
- DAOL Investment
DAOL Investment Valuation Multiples
Discover revenue and EBITDA valuation multiples for DAOL Investment and similar public comparables like Spectral Capital, VEF, Creal, Binhai Investment Co and more.
DAOL Investment Overview
About DAOL Investment
DAOL Investment & Securities Co Ltd. is a Korea-based company engaged in the business of financial services. The company offers a wide range of financial services, including securities, savings bank, asset management, venture capital, and private equity.
Founded
1981
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$1B
Valuation Multiples
Start free trialDAOL Investment Financials
DAOL Investment reported last fiscal year revenue of $237M.
In the same fiscal year, DAOL Investment generated $28M in net income.
DAOL Investment P&L
In the most recent fiscal year, DAOL Investment reported revenue of $237M and net income of $28M.
DAOL Investment is profitable as of last fiscal year, with net margin of 12%.
Financial data powered by Morningstar, Inc.
DAOL Investment Stock Performance
DAOL Investment has current market cap of $186M, and enterprise value of $1B.
DAOL Investment's stock price is $3.13.
DAOL Investment has an EPS (earnings per share) of $0.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $186M | -0.4% | — | — | — | $0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDAOL Investment Valuation Multiples
DAOL Investment trades at 5.8x EV/Revenue multiple.
DAOL Investment Financial Valuation Multiples
As of May 10, 2026, DAOL Investment has market cap of $186M and EV of $1B.
DAOL Investment has a P/E ratio of 6.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DAOL Investment Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


DAOL Investment Margins & Growth Rates
In the most recent fiscal year, DAOL Investment reported net margin of 12%.
DAOL Investment Margins
DAOL Investment Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
DAOL Investment Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
DAOL Investment Competitors
DAOL Investment competitors include Spectral Capital, VEF, Creal, Binhai Investment Co, Xlife Sciences, GalaxyEdge Acquisition, Triple Point Venture VCT, Auroora Group, Brockhaus Technologies and Kinea Oportunidades Real Estate FII.
Most DAOL Investment public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 9.0x | — | 96.0x | — | |||
| (366.0x) | — | 2.2x | — | |||
| 0.4x | — | 8.3x | — | |||
| 0.8x | — | 7.2x | — | |||
| 660.3x | — | (59.6x) | — | |||
| — | — | (3460.9x) | — | |||
| 76.2x | — | — | — | |||
| 1.0x | — | 10.4x | — | |||
This data is available for Pro users. Sign up to see all DAOL Investment competitors and their valuation data. Start Free Trial | ||||||
DAOL Investment Investment Activity
DAOL Investment has invested in 17 companies to date.
Latest investment by DAOL Investment was on March 8th 2023. DAOL Investment invested in Ascent Korea in their $23M Series A round (EV/Revenue multiple of ).
Latest Investments by DAOL Investment
| Description | — | Onconic Therapeutics Inc is a company that researches and develops new drugs for gastrointestinal diseases and anticancers, which have large unmet medical needs. Its pipeline products are Zataprazan(OCN-101) and OCN-201. | Balaan is a Seoul-based e-commerce platform specializing in luxury fashion and accessories sourced directly from European boutiques. The service delivers items from brands like Gucci and Dior to South Korean customers within three days at discounted prices compared to international retailers. | Qli5 Therapeutics is a Boston-headquartered biotech developing selective, non-covalent proteasome inhibitors for oncology. Its lead compounds target cancer cells with minimal off-target effects, advancing toward IND filing. Supported by venture funding, it collaborates with academic labs in the U.S. for preclinical validation. | |
| HQ Country | |||||
| HQ City | Seoul | — | Seoul | Dortmund | |
| Deal Date | 8 Mar 2023 | 9 Dec 2022 | 14 Oct 2022 | 7 Sep 2022 | |
| Round | Series A | Series B | Series C | Series A | |
| Raised | $23M | $20M | $18M | $10M | |
| Investors | DAOL Investment; Megazone; Shinhan Venture Investment; Smart T for Megazone Venture Investment Association | AJU IB Investment Co; BNH Investment; DAOL Investment; Dt& Investment; K2 Investment Partners; Korea Development Bank; Premier Partners; SL Investment; Stonebridge Ventures | Company K Partners; DAOL Investment; Shinhan Capital | Atinum Investment; DAOL Investment; KHAN Technology Transfer Fund; SV Investment | |
| Valuation | undisclosed | $47M | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all DAOL Investment investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DAOL Investment
| When was DAOL Investment founded? | DAOL Investment was founded in 1981. |
| Where is DAOL Investment headquartered? | DAOL Investment is headquartered in South Korea. |
| Is DAOL Investment publicly listed? | Yes, DAOL Investment is a public company listed on Korea Exchange. |
| What is the stock symbol of DAOL Investment? | DAOL Investment trades under 030210 ticker. |
| When did DAOL Investment go public? | DAOL Investment went public in 1996. |
| Who are competitors of DAOL Investment? | DAOL Investment main competitors include Spectral Capital, VEF, Creal, Binhai Investment Co, Xlife Sciences, GalaxyEdge Acquisition, Triple Point Venture VCT, Auroora Group, Brockhaus Technologies, Kinea Oportunidades Real Estate FII. |
| What is the current market cap of DAOL Investment? | DAOL Investment's current market cap is $186M. |
| What is the current revenue of DAOL Investment? | DAOL Investment's last fiscal year revenue is $237M. |
| What is the current EV/Revenue multiple of DAOL Investment? | Current revenue multiple of DAOL Investment is 5.8x. |
| Is DAOL Investment profitable? | No, DAOL Investment is not profitable. |
| How many companies DAOL Investment has acquired to date? | DAOL Investment hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies DAOL Investment has invested to date? | As of May 2026, DAOL Investment has invested in 17 companies. |
| What was the last DAOL Investment investment? | On 8th March 2023 DAOL Investment invested in Ascent Korea, participating in a $23M Series A round, alongside Megazone, Shinhan Venture Investment, and Smart T for Megazone Venture Investment Association. |
| In what companies DAOL Investment invested in? | DAOL Investment invested in TeamFresh, HUINNO, Balaan, onepredict, Apartmentary, Ascent Korea, Onconic Therapeutics, ORIG3N, Cleaning Lab, PharmCADD, MyMusicTaste, Qli5 Therapeutics, Rusk Media, Knowre, OPENSURVEY Incorporated, Craver, and Foodfly. |
See public comps similar to DAOL Investment
Lists including DAOL Investment
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

